Why Patient-Focused Research?
Progress in lung cancer, whether in diagnosis or treatment, is moving forward quickly. However, this progress is not always made with the direct input of the people who are actually living with this disease.
LUNGevity's Patient-Focused Research Center (Patient FoRCe) is a bridge to connect the patient voice with healthcare professionals, regulators, policymakers, and developers of drugs to ensure that voices like yours are heard and incorporated into the decisions that matter most.
Patient FoRCe's Mission
Patient FoRCe is changing how we think about lung cancer by removing assumptions about patient preferences and helping to generate conclusions from directly from patients and caregivers about what they value when it comes to their care.
Our Research Approach
Through numbers (surveys) and stories (focus groups and interviews), LUNGevity's Patient FoRCe team seeks to:
- Uncover misperceptions about patient and caregiver attitudes toward care, treatment, and support
- Identify and create awareness about areas of unmet need
Data from our studies, where we invite you, the patients and caregivers in this community, to participate and help us develop LUNGevity programs. Our findings are also used to advocate for improvements in healthcare delivery, policy, treatments, and research that affect people living with lung cancer.
Our projects are uniquely patient-focused and involve multiple stakeholders.
Publications
Explore the latest research findings from Patient FoRCe. Our team regularly publishes study results, reports, and peer-reviewed papers that advance understanding and support better patient outcomes. Browse the publications below to learn more.
- READ THE REPORTS
2026 Summary Report: Survey Findings from LUNGevity Foundation's Annual HOPE Summit (August 12, 2026)
HER2 Listening Session Report (August 12, 2026)
Patient FoRCe Results
Visit the Patient FoRCe News page to read about our research findings and subscribe to our Research Newsletter to get notified when new results are shared.
-
Where Do People Draw the Line When Balancing Treatment Benefits and Side Effects for Early-Stage Disease?
Read time: 1 minutes. For people with early-stage non-small cell lung cancer, expanding treatment options are welcome news—but they can also make decisions more complicated. Some -
What Is the Impact of Low-Grade Side Effects (Such As Diarrhea) on Patients’ Quality-of-Life?
Read time: 1 minute. When people hear the phrase “low grade” in cancer treatment, it can sound reassuring. But for patients, a side effect that is not life-threatening can still -
Testing an Innovative Approach To Promote Lung Cancer Screening in a Large Hospital System Serving Minority Populations
Read time: 1 minute. Getting screened for lung cancer can save lives, but many people who qualify for screening never receive it. A LUNGevity-supported study presented at the 2026
